Back
CNS Pharmaceuticals, Inc. Stock Predictions
$0.85 Entry Open - Fortune 1000 AI Tech in Demand
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
22
CNSP
CNS Pharmaceuticals, Inc.
Last Price:
$6.50
Seasonality Move:
-48.4%
7 Day Trial
ALL ACCESS PASS
$
7
Missed $0.81? RAD Intel Now Open at $0.85/Share
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiCNS Pharmaceuticals, Inc. Stock Forecast
-
Over the next 52 weeks, CNS Pharmaceuticals, Inc. has on average historically fallen by 55.6% based on the past 6 years of stock performance.
-
CNS Pharmaceuticals, Inc. has fallen lower in 6 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 100%
-
Is CNS Pharmaceuticals, Inc. Stock Undervalued?The current CNS Pharmaceuticals, Inc. [CNSP] share price is $6.51. The Score for CNSP is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
-
CNSP is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will CNS Pharmaceuticals, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, CNS Pharmaceuticals, Inc. has on average historically fallen by 55.6% based on the past 6 years of stock performance.
CNS Pharmaceuticals, Inc. Stock Rating
Sell
22
CNS Pharmaceuticals, Inc. (CNSP)
is a Sell
Is CNS Pharmaceuticals, Inc. overpriced?
-
CNS Pharmaceuticals, Inc. has fallen lower in 6 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 100%
CNS Pharmaceuticals, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
cnspharma.com
52-Week Data
52-Week High:
114.00
52-Week Low:
4.93
Prediction Charts
Market Cap:
4M
Price in USD:
6.51
Volume:
7.3K
Beta:
1.22
Technical Analysis
SMA50:
7.91
SMA100:
7.68
SMA200:
12.67
52-Wk Change:
-90.01%
Stock Predictions
-
Is CNS Pharmaceuticals, Inc. stock public?Yes, CNS Pharmaceuticals, Inc. is a publicly traded company.
-
What is the CNS Pharmaceuticals, Inc. stock quote today?The CNS Pharmaceuticals, Inc. stock price is 6.51 USD today.
-
How to buy CNS Pharmaceuticals, Inc. stock online?You can buy CNS Pharmaceuticals, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-14 | 6.04 | 6.90 | 6.90 | 6.04 |
| Nov-17 | 6.69 | 6.70 | 6.79 | 6.50 |
| Nov-18 | 6.51 | 6.73 | 6.73 | 6.51 |
| Nov-19 | 6.94 | 6.73 | 6.94 | 6.54 |
| Nov-20 | 6.96 | 6.51 | 6.96 | 6.30 |
| Nov-21 | 6.74 | 6.90 | 6.90 | 6.61 |
| Nov-24 | 6.92 | 6.84 | 7.07 | 6.75 |
| Nov-25 | 6.95 | 6.76 | 7.04 | 6.76 |
| Nov-26 | 6.94 | 6.74 | 7.66 | 6.62 |
| Nov-28 | 6.94 | 6.94 | 7.18 | 6.93 |
| Dec-1 | 6.90 | 6.88 | 7.10 | 6.87 |
| Dec-2 | 6.85 | 6.51 | 6.85 | 6.35 |
| Dec-3 | 6.44 | 6.66 | 6.66 | 6.11 |
| Dec-4 | 6.51 | 6.51 | 6.60 | 6.29 |
CNS Pharmaceuticals, Inc. Earnings
CNS Pharmaceuticals, Inc. Earnings Report: Per Share CNS Pharmaceuticals, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
CNS Pharmaceuticals, Inc. Forecast Revenue Growth
CNS Pharmaceuticals, Inc. Stock Analysis: Historical quarterly revenues per share for CNS Pharmaceuticals, Inc. and historical quarterly revenue growth:
* CNS Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.